Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a simple questionnaire reveal how COPD patients really feel?

NCT ID NCT01651676

First seen Nov 19, 2025 · Last updated Jun 23, 2026 · Updated 32 times

Summary

This study tested whether a questionnaire called VQ11 can accurately measure changes in quality of life for people with COPD who start taking a long-acting bronchodilator. Fifty-seven stable COPD patients filled out the VQ11 before and after three months of treatment. The goal was to see if a drop of 5 points on the VQ11 score reflects real improvement in daily life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CH Creil

    Creil, 60109, France

  • CH de DOUAI

    Douai, 59507, France

  • CHRU de Lille

    Lille, 59037, France

  • CHU Amiens Nord

    Amiens, 80054, France

  • CHU Amiens Sud

    Amiens, 80054, France

  • CHU de Rouen

    Rouen, 76000, France

  • Centre Hospitalier de Chauny

    Chauny, 02300, France

  • Centre Hospitalier de Compiègne

    Compiègne, 60200, France

  • Centre Médical

    Compiègne, 60200, France

  • Centre Médical

    Denain, 59220, France

  • Centre Médical

    Le Havre, 76600, France

  • Centre hospitalier de St Quentin

    Saint-Quentin, 02321, France

  • Clinique de l'Europe

    Amiens, 80000, France

  • Hopital Jacques MONOD

    Le Havre, 76083, France

  • Hopital Maison Blanche

    Reims, 51092, France

  • Résidence Saint Michel

    Valenciennes, 59300, France

  • Zac Gouraud

    Soissons, 02200, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

long-acting bronchodilator (beta-2 agonist or anticholinergic drug)

What this could lead to

If successful, this could show that the VQ11 questionnaire is a reliable tool for measuring quality-of-life improvements in COPD patients.

What could go wrong

This is a small, completed study focused on validating a questionnaire, not testing a new treatment. Results may not apply to all COPD patients.

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.